Antibiotic Resistance
Antibiotic resistance is the process by which bacteria [[how-evolution-works|evolve]] to survive the drugs designed to kill them, rendering once-miraculous medicines useless and threatening to return humanity to an era when a simple cut or a routine surgery could be fatal. [[alexander-fleming|Alexander Fleming]] himself predicted — in his [[nobel-prize|1945 Nobel lecture]] — the problem, warning that the inevitable misuse of [[the-discovery-of-penicillin|penicillin]] would breed resistant bacteria, an insight rooted in a fundamental paradox of evolutionary medicine: the selective pressure antibiotics create is precisely what drives resistance. The [[world-health-organization|World Health Organization]] has called antibiotic resistance one of the top ten greatest global public health threats, a classification that reflects both the scale of current deaths and the potentially catastrophic trajectory if the problem goes unsolved.
The Mechanism
Bacteria acquire resistance through random [[how-dna-works|genetic]] mutations or by picking up — through horizontal gene transfer, a process that allows resistance to jump across species boundaries within the shared [[the-microbiome|microbial ecosystem]] — resistance genes from entirely unrelated other bacteria. When an [[how-antibiotics-work|antibiotic]] is present, susceptible bacteria die and resistant ones — organisms that can reproduce every twenty minutes — survive, subject to the most intense selection pressure in nature. The reckless overuse of antibiotics in both human medicine and industrial agriculture accelerates this otherwise gradual process dramatically, turning hospitals and factory farms alike into breeding grounds for resistant strains. In human medicine, antibiotics are routinely prescribed for viral infections they cannot treat and courses are taken incompletely, allowing partially resistant bacteria to survive rather than die. Most — roughly 70% of all — antibiotics sold in the [[united-states|United States]] are used not to treat sick animals but to promote growth and prevent disease in overcrowded [[factory-farming|livestock operations]], making every sub-therapeutic dose in a feed lot an evolutionary laboratory.
The Crisis
The dire consequences are already measurable. Drug-resistant infections kill more than a million people worldwide each year, an estimated 1.27 million, with an additional 4.95 million associated deaths, a toll that already exceeds those of [[hiv-aids|HIV/AIDS]] or [[malaria|malaria]]. Some of the most alarming resistant strains, including the globally notorious [[mrsa|methicillin-resistant Staphylococcus aureus]], have become widespread hospital threats that represent a return to pre-antibiotic conditions in the very institutions designed to heal. Carbapenem-resistant bacteria — resistant to the antibiotics of last resort — have been called by the [[cdc|CDC]] "nightmare bacteria", a name that reflects not hyperbole but clinical reality: when these organisms cause bloodstream infections, [[how-your-immune-system-works|the immune system]] alone is often insufficient and mortality rates can exceed 50%. Projections suggest that by 2050, resistant infections could kill as many as ten million people annually — more than [[cancer|cancer]] — if current trends continue.
The Pipeline
The once-robust pipeline of new antibiotics is nearly empty. More than twenty new classes of antibiotics were introduced between 1940 and 1962 — the golden age of antibiotic discovery — but since then, only two genuinely new classes have reached the market, a stagnation driven by economics — antibiotics are used briefly and should be used sparingly, making them deeply unprofitable — and by the plain scientific reality that the easy targets have already been found. Researchers are exploring unconventional alternatives such as [[bacteriophages|bacteriophages]], antimicrobial peptides, and — most ambitiously — [[crispr|CRISPR]]-based approaches that target specific resistance genes, but none has yet successfully replaced conventional antibiotics. The miracle of antibiotics — every one of which has followed the same trajectory from introduction through miraculous efficacy, overuse, resistance, and obsolescence — was never permanent, and the window of unprecedented medical capability that opened with [[the-discovery-of-penicillin|Fleming's accidental discovery]] is closing, as the bacteria inexorably outpace the science.